Predictive factors for poor outcome in pediatric C3 glomerulonephritis
نویسندگان
چکیده
منابع مشابه
C3 glomerulonephritis in multiple myeloma
BACKGROUND C3 glomerulonephritis (C3 GN) is a recently defined entity characterized by predominant C3 deposition in glomeruli due to abnormal activation of the alternative pathway of complement system. C3 GN has been reported to be associated with several systemic diseases. However, the association between C3 GN and multiple myeloma (MM) has not been well established. METHODS We herein descri...
متن کاملFactors Affecting the Outcome of Bronchiectasis in Pediatric Patients
Introduction: Bronchiectasis is a common problem in children and early diagnosis can lead to early treatment and prevent of its complications. This study was aimed to evaluate factors effective on outcome of bronchiectasis in children. Methods: In an analytical cross-sectional study, 347 children with bronchiectasis Underwent the study. the patients were diagnosed based on chronic suppurative c...
متن کاملP-148: Predictive Factors for Pregnancy after Intrauterine Insemination: A Retrospective Study of Factors Affecting Outcome
Background: Controlled ovarian hyper stimulation (COH) in conjunction with intrauterine insemination (IUI) is frequently used to treat various causes of infertility in couples. In this study we evaluate the relation between IUI outcomes and infertility with the intent to detect the most important parameters that pertain to a successful IUI. Materials and Methods: In this cross-sectional study, ...
متن کاملpredictive factors of poor outcome in road traffic injures; a retrospective cohort study
introduction : road traffic injuries (rti) are among the most important health problems worldwide as they cause more than 1.2 million deaths and 50 million injuries each year. therefore, the present study aims to evaluate the outcome and aftermath of rti in those who were injured and hospitalized due to a traffic accident. methods : in the present retrospective cohort study with a one-year foll...
متن کاملTiming of eculizumab therapy for C3 glomerulonephritis
Eculizumab is an anti-C5 antibody that inhibits C5 cleavage and prevents the generation of the terminal complement complex C5b-9. Eculizumab is licensed to treat paroxysmal nocturnal haemoglobinuria or atypical haemolytic uraemic syndrome (aHUS). Clinical trials are ongoing for C3 glomerulopathy. Given the unfamiliarity of physicians with these rare diseases and the variability of clinical pres...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
سال: 2018
ISSN: 0016-2590,2185-4610
DOI: 10.5387/fms.2018-05